| Date | Time | Source | Headline | Symbol | Company |
| 04/20/2010 | 5:11PM | Dow Jones News | Gilead Lowers 2010 Product Sales View Citing Healthcare Reform | NASDAQ:GILD | Gilead Sciences Inc |
| 04/20/2010 | 4:54PM | Dow Jones News | Gilead Sciences 1Q Profit Up 45% On Strong HIV Drug Sales | NASDAQ:GILD | Gilead Sciences Inc |
| 04/20/2010 | 4:13PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 04/20/2010 | 4:05PM | Business Wire | Gilead Sciences Announces Record First Quarter 2010 Financial Results | NASDAQ:GILD | Gilead Sciences Inc |
| 04/20/2010 | 8:51AM | Business Wire | Gilead Provides Update on Development of Fixed-Dose Regimen of Truvada® and Tibotec Pharmaceuticals’ TMC278 | NASDAQ:GILD | Gilead Sciences Inc |
| 04/19/2010 | 8:30PM | Business Wire | Gilead Terminates Phase II Clinical Trial of GS 9450 in Patients With Chronic Hepatitis C | NASDAQ:GILD | Gilead Sciences Inc |
| 04/15/2010 | 6:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 04/13/2010 | 4:15PM | Business Wire | Gilead Sciences to Release First Quarter 2010 Financial Results on Tuesday, April 20, 2010 | NASDAQ:GILD | Gilead Sciences Inc |
| 04/12/2010 | 4:15PM | Business Wire | Gilead Initiates Phase III Clinical Program Evaluating Single-Tablet, Once-Daily “Quad” Regimen for HIV | NASDAQ:GILD | Gilead Sciences Inc |
| 04/07/2010 | 2:31PM | Dow Jones News | UPDATE: FDA Warns Biogen On Tysabri, Gilead On Truvada Promotions | NASDAQ:GILD | Gilead Sciences Inc |
| 04/07/2010 | 12:16PM | Dow Jones News | FDA Warns Biogen On Tysabri, Gilead On Truvada Promotions | NASDAQ:GILD | Gilead Sciences Inc |
| 04/06/2010 | 4:59PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 04/05/2010 | 6:20PM | Dow Jones News | Steven A. Cohen Raises His InterMune Stake To 8.2% | NASDAQ:GILD | Gilead Sciences Inc |
| 04/05/2010 | 4:16PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 03/26/2010 | 9:31AM | PR Newswire (US) | Critical Alerts for Amazon.com, Gilead Sciences, Weatherford International, Cemex, and SunTrust Released by Seven Summits Resear | NASDAQ:GILD | Gilead Sciences Inc |
| 03/22/2010 | 6:26PM | Dow Jones News | Gilead CEO Martin's Total 2009 Compensation Valued At $14.7 Million | NASDAQ:GILD | Gilead Sciences Inc |
| 03/22/2010 | 4:57PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:GILD | Gilead Sciences Inc |
| 03/19/2010 | 3:52PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:GILD | Gilead Sciences Inc |
| 03/17/2010 | 4:30PM | Business Wire | Gilead Sciences to Present at the Barclays Capital 2010 Global Healthcare Conference on Wednesday, March 24 | NASDAQ:GILD | Gilead Sciences Inc |
| 03/10/2010 | 8:29PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 03/10/2010 | 8:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 03/10/2010 | 8:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 03/10/2010 | 8:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 03/10/2010 | 8:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 03/10/2010 | 8:25PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 03/10/2010 | 1:50PM | Dow Jones News | UPDATE: Intermune Soars On FDA Panel, Buyout Speculation | NASDAQ:GILD | Gilead Sciences Inc |
| 03/04/2010 | 4:30PM | Business Wire | Gilead Sciences to Present at the Cowen and Company 30th Annual Health Care Conference on Thursday, March 11 | NASDAQ:GILD | Gilead Sciences Inc |
| 03/03/2010 | 6:51PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 03/01/2010 | 4:28PM | Edgar (US Regulatory) | Annual Report (10-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 03/01/2010 | 11:52AM | Dow Jones News | 2nd UPDATE: Astellas Plans Unsolicited $3.5 Billion Bid For OSI | NASDAQ:GILD | Gilead Sciences Inc |